Divergent pathways of surfactant protein C maturation for disease-associated isoforms
Year: 2026
Type: article
Abstract: ABSTRACT Surfactant Protein C (SP-C), a hydrophobic protein exclusively synthesized and secreted by alveolar type II (AT2) cells, is important for reducing alveolar surface tension in the distal lung. Chronic interstitial pulmonary diseases have been associated with SFTPC mutations. However, a detailed understanding of SP-C maturation in the secretory pathway and disruptions caused by mutations has remained incomplete. The goal of this study was to comprehensively ascertain differences in trafficking and post-translational processing between wild-type and disease-associated SP-C mutants using doxycycline-inducible mouse lung epithelial (MLE-12) cell lines expressing either wildtype SP-C or the common clinical variant SP-C I73T , validated using primary AT2 cells isolated from a murine SP-C I73T pulmonary fibrosis model and induced pluripotent stem cell (iPSC)-derived human alveolar type 2 cells (iAT2s) expressing the same mutant. In all 3 models SP-C WT was highly concentrated in acidic LROs while SP-C I73T accumulated on the plasma membrane, which was corroborated by inhibition of clathrin-mediated endocytosis, surface biotinylation, immunogold EM, immunofluorescent staining in non-permeabilized cells, and proteinase K protection assays supporting divergence of SP-C I73T trafficking from SP-C WT . The exclusion of SP-C I73T from normal routing occurred early in the biosynthetic pathway as Brefeldin A blocked processing of both SP-C proproteins, while a 20°C temperature shift caused selective accumulation of a processed proSP-C WT intermediate, suggesting initial C-terminal cleavage of proSP-C WT occurs in late-Golgi/ trans-Golgi network (TGN). This cleavage event was sensitive to DC1, an inhibitor of furin-related subtilisin-like proprotein convertase (PPC) family members. Site-directed mutagenesis of canonical residues K160, R167 within a predicted PPC recognition site in the proSP-C BRICHOS domain blocked its processing. Expression constructs encoding inhibitory pre-proprotein (pp) peptide fragments of Furin and ppPC7 each inhibited cleavage of proSP-C WT by MLE-12 cells. Collectively, our data demonstrate that trafficking pathways for maturation of WT and mutant I73T SP-C diverge prior to the TGN where initial cleavage of the COOH-terminal SP-C propeptide occurs via a Furin-like proprotein convertase.
Source: Journal of Biological Chemistry
Authors: Sarah Bui, Anamarie Reineberg, Dakota Jones, Cheng-Lun Na, Joseph Kitzmiller, Luis R. Rodriguez, Aditi Murthy, Swati Iyer, Charlotte Cooper, Rea Chroneos, Yaniv Tomer, Surafel Mulugeta, Timothy E. Weaver, Darrell N. Kotton, Konstantinos-Dionysios Alysandratos, Jeffrey A. Whitsett, Michael F. Beers
Language: English
Subfield: Cell Biology
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $3,430
Awards: G1152303687, G1309894558, G1782747546, Biosynthesis and Trafficking of Surfactant Protein C In Health and Disease, G1920124341, G2097129609, Developing a patient-specific organoid model of pulmonary fibrosis using iPSCs, Editing Alveolar Progenitor Cells for Correction of Monogenic Disease, The role of Alveolar Epithelial Cell Metabolic Reprogramming in Idiopathic Pulmonary Fibrosis, G2710407875, G2744122932, G2789961788, G284177124, Epithelial stem/progenitor cells as repair agents in diffuse alveolar damage, G3819567333, G3894520524, Research Center for Spatiotemporal Lung Imaging and Omics, G5343579410, G54343121, G594147353, Generation of functional lung stem cells from human iPSCs, Aging and Metabolic Dysfunction Drive Disrupted Alveolar Epithelial Progenitor Function in Pulmonary Fibrosis, G6585965511, G7155016862, Role of EMC3/TMEM111 in Alveolar Epithelial Cell Function, G8293452648, Alveolar Epithelial Cell Dysfunction in Pulmonary Fibrosis: Leveraging SFTPC Mutations for Discovery of Molecular and Cellular Targets, Utilizing induced pluripotent stem cells to study the role of alveolar type 2 cell dysfunction in pulmonary fibrosis, Developing Pluripotent Stem Cells to Model and Treat Lung Disease, Derivation of lung epithelia from iPS cells for advanced disease modeling
OpenAlex ID: W7128078829
